featured
Overall Survival After 5 Years in Patients With Locally Advanced SCCHN Treated With Xevinapant Plus Chemoradiotherapy vs Placebo Plus CRT
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.